Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - IDCW Reinvestment
NAV as on 2026-07-17 · Equity · Index
AUM
₹182 Cr
1Y Return
+11.7%
3Y CAGR
-
5Y CAGR
-
Expense
0.40%
Risk
Very High
1Y Return
+11.7%
3Y CAGR
-
5Y CAGR
-
Since Inception
+19.3%
AI Fund Analysis
Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.
NAV History
Drag or scroll the chart to pan through history
52-Week NAV Range
94% from 52W low
Fund Information
Fund House
Tata Mutual Fund
Category
Equity - Index
Min SIP
₹500
Min Lumpsum
₹5,000
Portfolio Composition
Asset Allocation
Market Cap Split
Top Holdings
Lupin Ltd
Healthcare
Fortis Healthcare Ltd
Healthcare
Laurus Labs Ltd
Healthcare
Aurobindo Pharma Ltd
Healthcare
Glenmark Pharmaceuticals Ltd
Healthcare
Alkem Laboratories Ltd
Healthcare
Biocon Ltd
Healthcare
Mankind Pharma Ltd
Healthcare
Ipca Laboratories Ltd
Healthcare
Aster DM Healthcare Ltd Ordinary Shares
Healthcare
Sector Allocation
Fundamentals
P/E Ratio
39.32
Cat avg: 24.05
P/B Ratio
5.21
Cat avg: 3.79
Dividend Yield
0.48%
Cat avg: 1.58%
Price/Sale
5.53
Price/Cash Flow
27.06
Peer Comparison
| Fund | AUM (Cr) | Exp % | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Tata Nifty MidSmall Hlthcr Idx DirIDCW-R | 182 | 0.40 | +11.7% | - | - |
| DSP BFSI Next Index Fund Dir IDCW-P | - | 0.28 | - | - | - |
| UTI Nifty 50 Index Fund IDCW-P | 28,685 | 0.26 | -2.1% | +8.3% | +9.9% |
| ICICI Pru Nifty 50 Index Dir IDCW-P | 16,839 | 0.17 | -2.2% | +8.3% | +9.8% |
| SBI Nifty Index Dir IDCW-P | 13,646 | 0.19 | -2.2% | +8.3% | +9.9% |
| ICICI Pru Nifty Next 50 Index Dir IDCW-P | 9,476 | 0.26 | +5.0% | +17.7% | +13.3% |
| Nippon India Index Nifty 50 Dir AnnIDCWP | 3,792 | 0.06 | -2.1% | +8.3% | +9.9% |
| Nippon India Nifty Smallcap250IDirIDCW-P | 3,294 | 0.30 | 0.0% | +17.5% | +14.7% |
| Bandhan Nifty 50 Index Dir IDCW-P | 2,702 | 0.08 | -2.1% | +8.3% | +9.9% |
| Nippon India Nifty Midcap150IdxDirIDCW-P | 2,587 | 0.25 | +4.7% | +19.0% | +17.3% |
What If I Had Invested?
NAV history not available for this range
Key Metrics
Risk-o-Meter
Low
Moderate
High
Very High
Rated as Very High risk
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.